The Law of Compounding Medications And Drugs

Thursday, August 28, 2014

tulsa.craigslist.org › all jobs › healthcare jobs

15 hours ago - ... http://apothecarytulsa.com Email all resumes. Company Overview: Lees Specialty Compounding Inc. - The ESOP parent company of The Apothecary Shoppe.

FDA Animal Veterinary Draft Guidance for Industry - VICH GL53 - Electronic Exchange of Documents: File Format Recommendations –

Draft Guidance for Industry - VICH GL53 - Electronic Exchange of Documents: File Format Recommendations – http://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/UCM411451.pdf

Wednesday, August 27, 2014

Alleged Landmark Compounding Medication Scheme Cost Carriers $105 Million Dollars; Patients Starting to Comment and Indicate they received no instructions with compounded medications

https://ww3.workcompcentral.com/news/story/id/89e94de79d40fac826e461c63e8832e2c5903aa2

Agenda for State of New Jersey Meeting August 27 2014

Board of Pharmacy - State of New Jersey

www.nj.gov/lps/ca/pharm/agenda/pharage_082714.pdf

15 hours ago - BOARD OF PHARMACY. OPEN SESSION AGENDA. MONMOUTH CONFERENCE ROOM, 7TH FLOOR. August 27, 2014. I. CALL TO ORDER. II. SUNSHINE ...

PhRMA jumps into Integrilin off-label case, free-speech arguments at the ready

It was inevitable. When a U.S. circuit court decided the First Amendment protected a pharma sales rep from off-label marketing charges, the free-speech arguments had to multiply. And they have, in cases across the country, testing that Second Circuit decision in other regions.
The latest: PhRMA jumped into a California False Claims Act (FCA) case, with a friend-of-the-court brief defending Millennium Pharmaceuticals, Schering-Plough and Merck's right to talk up unapproved uses of the clot-fighting drug Integrilin.
It's a wisely chosen target: The case, filed by former Millennium sales rep Frank Solis, hinges on journal articles that the company allegedly distributed to doctors, along with letters summarizing the studies. Schering-Plough copromoted Integrilin with Millennium, and Merck ($MRK) bought Schering in 2009.
http://www.fiercepharmamarketing.com/story/phrma-jumps-integrilin-label-case-free-speech-arguments-ready/2014-08-27?utm_medium=nl&utm_source=internal

Horse Doping: Jones: "Either we eliminate the problem, or the problem is going to eliminate us"

But given the network of state regulatory bodies, how would you envision The Jockey Club’s role working? And where would it get the authority to actually take punitive actions other than pulling a horse’s registration, for example?

“We need to strengthen the penalties for doping horses, for example, and then you need to give that job of enforcement to somebody like the United States Anti-Doping Agency [USADA]. If you have USADA in control of that under the larger umbrella of The Jockey Club, it would seem to me that you would have your best opportunity of doing this properly. But what’s happened in the horse industry is that there’s been too much wrist-slapping when rules are broken and not enough penalties applied for these broken rules.”